Cannabinoids for Autism
This Evidence Watch reviews a 2026 systematic review on cannabinoids for autism in children and adolescents. The paper found limited RCT evidence, with one whole-plant high-CBD, low-THC extract showing improvement in global clinical impression and social…
What Pediatric Autism Cannabinoid Studies Actually Show
Cannabinoids for autism behavior are increasingly discussed by families seeking help for irritability, aggression, sleep, anxiety, and daily functioning. This review finds a limited but clinically relevant signal for selected outcomes, especially with…
Drugs detected in suspected pediatric exposures: a 5-year review.
A 5-year hospital study found pediatric cannabis exposure emergency department detection patterns showing cannabis metabolites among the most frequently identified compounds in children presenting with suspected toxic ingestions. This surveillance data…
Cannabidiol blood metabolite levels after cannabidiol treatment are associated with broadband EEG changes and improvements in visuomotor and non-verbal cognitive abilities in boys with autism requiring higher levels of support.
A rigorous clinical trial found that CBD autism spectrum disorder clinical trial results showed measurable brain activity changes in children with high-support autism. While promising for understanding CBD's neurological effects, the study did not…
Pediatric Hemp-Derived Cannabinoid and Δ9-THC Exposures: A National Poison Data Study.
A major poison center study reveals that hemp-derived cannabinoids pediatric toxicity rates exceed those of delta-9-THC in accidental exposures. This challenges the common assumption that hemp products are safer alternatives, showing higher rates of…
Early-life exposure to Cannabidiol: Safety assessment of a chronic exposure in Caenorhabditis elegans.
Recent toxicology research examining CBD safety in early development reveals dose-dependent safety profiles with oxidative stress mechanisms. This preclinical work provides important insights for pediatric CBD applications while highlighting the need for…
Cannabinoid-based interventions for behavioral outcomes in children and adolescents with autism spectrum disorder: A systematic review of safety and effectiveness.
A comprehensive systematic review examining cannabinoids for autism in children and adolescents reveals promising response rates of 49% versus 21% placebo, though evidence quality limitations require careful clinical interpretation. The review…
Tween, Teen Cannabis Use Linked to Slower Cognitive Development – Psychiatry Advisor
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Adolescent MedicineCognitive…
New UC San Diego Study on Teen Cannabis Use and Cognitive Development
Adolescent cannabis cognitive effects are a growing concern as UC San Diego research reveals slower cognitive processing in teens who use marijuana. This study highlights the neurodevelopment risks associated with cannabis use during critical growth…
The Impact of Cannabis on Young Brains: Clinical Insights
Adolescent cannabis use linked to slower cognitive development is a growing concern in pediatric health. Understanding the impact of cannabis on young brains is essential for risk assessment. Clinicians must carefully evaluate cannabis use during…